Intellectual Property News & Topics - Secerna LLP

Morning Sickness Drugs Repurposing

Morning Sickness: The Role of Drug Repurposing and Intellectual Property Considerations

News 17/09/2024

Recent breakthroughs in understanding the underlying causes of morning sickness offer exciting opportunities for drug repurposing. Learn how researchers can leverage existing medications to develop innovative treatments for this common pregnancy symptom.

Read more

JP3 2544

Industry news, News 05/07/2023

Secerna LLP Receives Ongoing Recognition as a Leading Firm by IAM 1000

Antibodies_Testing_Image

News 04/07/2023

Assessing Inventive Step of Antibodies at the European Patent Office

B012853

Team news, Careers 20/06/2023

Grace Holliday in profile

Dermot GB2 1498 Nov 22

Events 18/06/2023

Secerna to attend Dublin IP and R&D Summit

Secerna Header Images (3)

Events, News 12/06/2023

Secerna LLP to attend BioFocus 2023 in Newcastle

GB2 4127

News, Team news 08/06/2023

Secerna appoints marketing lead to fuel growth

EU Flag UPC article

European, News 01/06/2023

New era for European patent law as unified patent system takes effect

AI Image Secerna LLP

News 23/05/2023

The UK and the EU: Taking different approaches to AI regulation

Dermot GB2 1498 Nov 22

Events 22/05/2023

Secerna to attend Dublin Tech Summit 2023

7 8 9 10 11 12 13 14 15 16 17